{"id":61208,"date":"2025-05-06T13:02:30","date_gmt":"2025-05-06T11:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/"},"modified":"2025-05-06T13:02:30","modified_gmt":"2025-05-06T11:02:30","slug":"bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/","title":{"rendered":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer"},"content":{"rendered":"
\n

\nGallman\u2019s Appointment is Effective Immediately<\/i>\n<\/p>\n

\nSandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service<\/i>\n<\/p>\n

PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb<\/a> (NYSE: BMY) today announced the appointment of Cari Gallman<\/a> as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after an extraordinary 33-year career at the company.\n<\/p>\n

<\/a>
<\/a>
<\/a>
<\/a><\/p>\n

\nGallman, an accomplished leader with extensive experience in pharmaceutical law and compliance, will lead the law department, which includes intellectual property, commercial and regulatory law, litigation, securities and corporate governance, transactions, corporate security and compliance and ethics, as well as global and U.S. policy and government affairs. She has held leadership positions at Bristol Myers Squibb for 10 years, most recently serving as Executive Vice President, Corporate Affairs.\n<\/p>\n

\n\u201cCari brings a unique combination of legal, policy and communications expertise, coupled with an impressive ability to inspire teams, uphold ethical business practices and champion patient voices,\u201d said Christopher Boerner, Ph.D.<\/a>, board chair and chief executive officer, Bristol Myers Squibb. \u201cI am confident that under Cari\u2019s leadership, our legal and policy teams are well positioned to advance Bristol Myers Squibb\u2019s efforts to drive and deliver innovation to patients facing serious diseases.\u201d\n<\/p>\n

\n\u201cIt is an honor to have the opportunity to lead the incredible teams that govern and counsel Bristol Myers Squibb in advancing its mission to deliver transformational medicines to more patients,\u201d said Gallman. \u201cI am committed to continuing to build on the company\u2019s culture of integrity and shape a dynamic policy environment that protects innovation and patients.\u201d\n<\/p>\n

\nOn Sandy\u2019s retirement, Boerner said, \u201cSandy\u2019s resilience, steadfast leadership, and unwavering commitment to patients have left an indelible mark on our company. On behalf of the entire organization, I want to express our deepest gratitude to Sandy for her decades of service and wish her all the best in her well-deserved retirement.\u201d\n<\/p>\n

\nAbout Cari Gallman<\/b>\n<\/p>\n

\nPrior to her appointment as Bristol Myers Squibb\u2019s Executive Vice President, General Counsel and Chief Policy Officer, Cari Gallman served as Executive Vice President, Corporate Affairs and was responsible for advancing the company strategy through strategic communications, government relations and policy, corporate social responsibility, corporate marketing and brand reputation, and patient advocacy.\n<\/p>\n

\nPreviously, Gallman served as Chief Compliance and Ethics officer, where she championed Bristol Myers Squibb\u2019s culture of integrity, ensuring the company conducted its business in compliance with ethical business practices and laws and regulations in the global markets in which it operates. Gallman joined Bristol Myers Squibb in 2015 and assumed positions of increasing responsibility, including as head of the legal team supporting the Global Oncology Commercialization and Development organizations.\n<\/p>\n

\nGallman began her legal career in private practice representing pharmaceutical and medical device manufacturers in a variety of complex civil, regulatory, and government enforcement matters.\n<\/p>\n

\nGallman earned a bachelor\u2019s degree in political theory from Princeton University, magna cum laude<\/i>, and a JD from Harvard Law School.\n<\/p>\n

\nAbout Bristol Myers Squibb: Transforming Patients\u2019 Lives Through Science
\n
<\/span><\/b>At Bristol Myers Squibb, our mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. We are pursuing bold science to define what\u2019s possible for the future of medicine and the patients we serve. For more information, visit us at BMS.com<\/a> and follow us on LinkedIn<\/a>, X<\/a>, YouTube<\/a>, Facebook<\/a> and Instagram<\/a>.\n<\/p>\n

\ncorporatefinancial-news\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor more information, contact:<\/b>
Media Relations: media@bms.com<\/a>
Investor Relations: investor.relations@bms.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Gallman\u2019s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61208","6":"format-standard","7":"category-industry"},"yoast_head":"\nBristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Gallman\u2019s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-06T11:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer\",\"datePublished\":\"2025-05-06T11:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/\"},\"wordCount\":594,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250506937441\\\/en\\\/2459549\\\/22\\\/CG_Image.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/\",\"name\":\"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250506937441\\\/en\\\/2459549\\\/22\\\/CG_Image.jpg\",\"datePublished\":\"2025-05-06T11:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250506937441\\\/en\\\/2459549\\\/22\\\/CG_Image.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250506937441\\\/en\\\/2459549\\\/22\\\/CG_Image.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/","og_locale":"en_US","og_type":"article","og_title":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend","og_description":"Gallman\u2019s Appointment is Effective Immediately Sandra Leung, Executive Vice President, General Counsel Retires After 33 Years of Service PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced the appointment of Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer, effective immediately. Gallman succeeds Sandra (Sandy) Leung, who has chosen to retire after ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/","og_site_name":"Pharma Trend","article_published_time":"2025-05-06T11:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer","datePublished":"2025-05-06T11:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/"},"wordCount":594,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/","url":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/","name":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg","datePublished":"2025-05-06T11:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250506937441\/en\/2459549\/22\/CG_Image.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/bristol-myers-squibb-appoints-cari-gallman-as-executive-vice-president-general-counsel-and-chief-policy-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61208"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61208\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}